Replies to post #60665 on Biotech Values

[exwannabe]

Re FLML Coreg dates

The OP was about the flame out in 2007, so these dates certainly seam reasonable.

But I will disagree with Dew and go with the majority opinion that Coreg-CR can not sell against the generic Coreg-IR at a fraction of the price.

Did FLML (or the patent holder) file suit against the challanger? If not, the the generic -CR will be on market in less than a year.

[DewDiligence]

>FLML – oops almost missed the dates
11/19/2007
12/21/2007
not exactly timely info, right?<

Actually, it is timely.

The FDA disclosed the Paragraph-IV challenge for Coreg CR this week. The dates cited above were when the ANDA’s for the two doses of Coreg CR were submitted.

The FDA keeps the existence of a Paragraph-IV challenge confidential until the ANDA in question is accepted for filing purposes.